Successful treatment with pemetrexed, Carboplatin, and bevacizumab for platinum-resistant adenocarcinoma of the lung.

about

Successful treatment with pemetrexed, Carboplatin, and bevacizumab for platinum-resistant adenocarcinoma of the lung.

Item

http://www.wikidata.org/entity/Q42222934

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Successful treatment with peme ...... nt adenocarcinoma of the lung.

@en

Successful treatment with peme ...... nt adenocarcinoma of the lung.

@nl

type

Item

label

Successful treatment with peme ...... nt adenocarcinoma of the lung.

@en

Successful treatment with peme ...... nt adenocarcinoma of the lung.

@nl

prefLabel

Successful treatment with peme ...... nt adenocarcinoma of the lung.

@en

Successful treatment with peme ...... nt adenocarcinoma of the lung.

@nl

P1476

Successful treatment with peme ...... nt adenocarcinoma of the lung.

@en

P2093

Katsuichiro Ono

http://www.w3.org/2001/XMLSchema#string

Kenichi Gemba

http://www.w3.org/2001/XMLSchema#string

Michiko Asano

http://www.w3.org/2001/XMLSchema#string

Nobukazu Fujimoto

http://www.w3.org/2001/XMLSchema#string

Sae Wada

http://www.w3.org/2001/XMLSchema#string

Shinji Ozaki

http://www.w3.org/2001/XMLSchema#string

Takumi Kishimoto

http://www.w3.org/2001/XMLSchema#string

Yasuko Fuchimoto

http://www.w3.org/2001/XMLSchema#string

P2860

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.

Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.

Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer.

P304

821280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1155/2012/821280

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229018179

http://www.w3.org/2001/XMLSchema#string

P698

22779020

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

P932

3388291

http://www.w3.org/2001/XMLSchema#string